Baxter Recalls Clindamycin Injection Due to Manufacturing Deviations
Baxter Healthcare is voluntarily recalling specific lots of Clindamycin Injection due to CGMP deviations. The affected product was distributed in the US, Puerto Rico, and Chile.
- Product
- CLINDAMYCIN PHOSPHATE — CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)
- Category
- Drug
- Distribution
- Distributed nationwide